ŸÀÌƲÇмú´ëȸ ¾È³»

ÀÏ ½Ã
2020³â 10¿ù 23ÀÏ(±Ý) 12:30 ~ 18:00
¹æ ¹ý
Online (ÃßÈÄ Á¢¼Ó¹æ¹ý ¾È³» ¿¹Á¤!)
Æò Á¡
´ëÇÑÀÇ»çÇùȸ 3ÆòÁ¡ ¿¹»ó
»çÀüµî·Ï ±â°£
2020³â 9¿ù 21ÀÏ(¿ù) - 10¿ù 19ÀÏ(¿ù)±îÁö
µî ·Ï ºñ
Àü¹®ÀÇ 30,000¿ø, Àü°øÀÇ / °£È£»ç / ±âŸ 20,000¿ø
°èÁ¹øÈ£
KEBÇϳªÀºÇà 501-910052-96405 (¿¹±ÝÁÖ : ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ)

ŸÀÌƲÇÁ·Î±×·¥



12:30 - 13:30 ÆòÀÇ¿øȸ
13:30 - 13:40 Opening Remarks ÀÓ¿µÅ¹ ȸÀå´Ô / ±¹ÈÆ ÀÌ»çÀå´Ô
Session ¥° JSPHO/KSPHO Joint Symposium: Bone tumor
13:40 - 14:10 Current trends in management of osteosarcoma ÀÌÁØ¾Æ (±¹¸³¾Ï¼¾ÅÍ)
14:10 - 14:40 Adjuvant chemotherapy for osteosarcoma patients Haki Hiraga (National Hospital Organization Hokkaido Cancer Center)
14:40 - 15:10 Current trends in management of Ewing sarcoma family of tumors ÇÑÁ¤¿ì (¿¬¼¼ÀÇ´ë)
15:10 - 15:40 Current status and future perspectives of Japanese clinical trial for Ewing sarcoma: Japan Ewing Sarcoma Study Group Hideki Sano (Fukushima Medical University Hospital)
15:40 - 16:00 Break
Session ¥± Cancer predisposing Syndrome
16:00 - 16:30 Overview of Cancer Predisposing Syndrome ÀÌÁö¿ø (¼º±Õ°üÀÇ´ë)
16:30 - 17:00 Multidisciplinary Approach for NF1 ±èÇý¸® (¿ï»êÀÇ´ë)
17:00 - 17:30 Germline mutation °ü·Ã ÁÖÁ¦ ÀÓÁö¼÷ (°¡Å縯ÀÇ´ë)
Session ¥²  ½Ã»ó ¹× ¾È³»
17:30 - 18:00 ÃÑȸ ¹× ½Ã»ó½Ä